May 2, 2025 — The last legitimate path for GLP-1 compounding closes on May 22 and consumer protection advocates are worried about rabbit holes opening up to exploit the desperation of some patients. Yesterday, the National Consumer League (NCL) released survey results to suggest a great deal of confusion and misinformation about off-brand versions of GLP-1 medicines. Perhaps more […]
September 12, 2023 — People are beginning to discover a major side effect of advanced meds for obesity that is not gastrointestinal – it’s economic disruption. Retailers, food makers, and participants in the huge business of health systems are all just starting to wrap their heads around the disruptive potential of more accessible and effective obesity treatment. Already, the […]
June 1, 2022 — When “health plans” tell someone seeking treatment for obesity it’s a vanity thing, we are not fooled. They simply don’t want to pay the bill. Health plan? Not really. It’s a lot like car insurance. It pays for a wreck. Not so much for preventing one. Writing in the New York Times today, Gina Kolata […]
